Andrew Dean

Andrew Dean is a researcher affiliated with the Faculty of Health at Queensland University of Technology (QUT), specializing in immunological research targeting Chlamydia infections. His work focuses on vaccine development, immune response mechanisms, and animal models for infectious diseases. Key collaborations include projects with Kenneth Beagley and Peter Timms, investigating mucosal immunity in koalas and IL-17 signaling pathways. Dean's research emphasizes understanding gender-specific immunity and optimizing vaccine delivery methods, particularly through intranasal routes. He has contributed to studies on chronic pathological changes in Chlamydia infections and the efficacy of recombinant vaccines in guinea pigs and mice.

His publications span 2011–2016, with notable contributions to Mucosal Immunology, Vaccine, and Immunology and Cell Biology. Research highlights include:

• Development of partial immunity strategies to block sexual Chlamydia transmission
• Advancing koala-specific immunization protocols against Chlamydia pecorum
• Elucidating IL-17's role in balancing protective vs. pathogenic immune responses
• Comparative vaccine studies in murine and guinea pig models

While no specific academic rank is stated, his active publication record aligns with a Researcher role in infectious disease and immunology.